Ataga, Kenneth I.

Crizanlizumab for the prevention of pain crises in sickle cell disease.

Ataga, K. I., Kutlar, A., Kanter, J., Liles, D., Cancado, R., Friedrisch, J., Guthrie, T. H., Knight-Madden, J., Alvarez, O. A., Gordeuk, V. R., et al. (2017) · New England Journal of Medicine

Hemoglobinopathies and Related DisordersBlood groups and transfusion

Cited by 914

The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up

Steinberg, M. H., McCarthy, W. F., Castro, O., Ballas, S. K., Armstrong, F. D., Smith, W., Ataga, K., Swerdlow, P., Kutlar, A., DeCastro, L., et al. (2010) · American Journal of Hematology

Hemoglobinopathies and Related DisordersBlood groups and transfusion

Cited by 486

Pulmonary hypertension in patients with sickle cell disease: a longitudinal study

Ataga, K. I., Moore, C. G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A., & Orringer, E. P. (2006) · British Journal of Haematology

Hemoglobinopathies and Related DisordersPulmonary Hypertension Research and Treatments

Cited by 298

Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe

Maitra, P., Caughey, M., Robinson, L., Desai, P. C., Jones, S., Nouraie, M., Gladwin, M. T., Hinderliter, A., Cai, J., & Ataga, K. I. (2017) · Haematologica

Hemoglobinopathies and Related DisordersBlood groups and transfusion

Cited by 137

Estimated pulmonary artery systolic pressure and sickle cell disease: a meta‐analysis and systematic review

Caughey, M. C., Poole, C., Ataga, K. I., & Hinderliter, A. L. (2015) · British Journal of Haematology

Hemoglobinopathies and Related DisordersPulmonary Hypertension Research and Treatments

Cited by 41

Monocytosis is associated with hemolysis in sickle cell disease

Wongtong, N., Jones, S., Deng, Y., Cai, J., & Ataga, K. I. (2015) · Hematology

Hemoglobinopathies and Related DisordersBlood groups and transfusion

Cited by 35